Suchergebnisse - "Yi, Zongbi"

PubPharm (55)

11

CandidateDrug4Cancer: An Open Molecular Graph Learning Benchmark on Drug Discovery for Cancer

enthalten in: arXiv.org | 2022

von Ye, X. | Li, Z. | Ma, F. | +6

12

Characteristics of homologous recombination repair pathway genes mutation in ovarian cancers

enthalten in: Cancer Innovation | 2022

von Yi, Z. | Chen, M. | Sun, S. | +5

13

Molecular landscape of TP53 mutations in breast cancer and their utility for predicting the response to HER‐targeted therapy in HER2 amplification‐positive and HER2 mutation‐positive amplification‐negative patients

enthalten in: Cancer Medicine | 2022

von Liu, B. | Yi, Z. | Guan, Y. | +10

14

Antibody-drug conjugates in HER2-positive breast cancer

enthalten in: Chinese medical journal | 2021

von Li, L. | Zhang, D. | Liu, B. | +5

15

Profile, treatment patterns, and influencing factors of anthracycline use in breast cancer patients in China : A nation-wide multicenter study

enthalten in: Cancer medicine | 2021

von Guo, F. | Yi, Z. | Wang, W. | +27

16

The molecular tumor burden index as a response evaluation criterion in breast cancer

enthalten in: Signal transduction and targeted therapy | 2021

von Yi, Z. | Ma, F. | Rong, G. | +10

17

CDK12 inhibition enhances sensitivity of HER2+ breast cancers to HER2-tyrosine kinase inhibitor via suppressing PI3K/AKT

enthalten in: European journal of cancer (Oxford, England : 1990) | 2021

von Li, H. | Wang, J. | Yi, Z. | +9

18

DNA damage response as a prognostic indicator in metastatic breast cancer via mutational analysis

enthalten in: Annals of translational medicine | 2021

von Rong, G. | Yi, Z. | Ma, F. | +4

19

Epithelial-Mesenchymal-Transition-Like Circulating Tumor Cell-Associated White Blood Cell Clusters as a Prognostic Biomarker in HR-Positive/HER2-Negative Metastatic Breast Cancer

enthalten in: Frontiers in oncology | 2021

von Guan, X. | Li, C. | Li, Y. | +8

20

Profile, treatment patterns, and influencing factors of anthracycline use in breast cancer patients in China : A nation‐wide multicenter study

enthalten in: Cancer Medicine | 2021

von Guo, F. | Yi, Z. | Wang, W. | +27